Rapid Molecular STI Test

About Rapidemic

Rapidemic is an early-stage diagnostics company developing a proprietary molecular testing platform for the rapid and accurate detection of STIs like Chlamydia and Gonorrhea at the point of care. The company aims to address the critical gap in current diagnostics, which are often either slow but accurate (central lab PCR) or fast but unreliable (rapid antigen tests). Backed by notable grants and venture funding, including support from the Bill & Melinda Gates Foundation, Rapidemic is positioning itself to capture a significant share of the global STI testing market by enabling single-visit diagnosis and at-home testing.

Therapeutic Areas